Literature DB >> 24093309

Infection rates, fevers, and associated factors in pediatric severe traumatic brain injury.

Ibrahim M Alharfi1, Tanya Charyk Stewart, Ibrahim Al Helali, Hani Daoud, Douglas D Fraser.   

Abstract

Abstract Infections can increase medical costs and worsen patient outcomes. Our aims in pediatric severe traumatic brain injury (sTBI) patients were to determine the infection and fever rates, and to report on associated clinical, imaging, treatment, and outcome factors. We included 180 sTBI patients (presedation Glasgow Coma Scale ≤ 8 and Maximum Abbreviated Injury Scale ≥ 4) admitted to our pediatric intensive care unit. Overall, 17% of sTBI patients (n=30 of 180) developed 36 infections, consisting primarily of urinary tract infections (UTIs; n=13 of 36) and ventilator-associated pneumonias (n=11 of 36). Most infections were nosocomial, occurring >2 days after admission. Fever was found in 36% of sTBI patients during the first few hospital days, but fewer than 7% of patients had infections. Infections occurred more frequently in sTBI patients who were older, heavier, and with a higher injury severity score (ISS; p<0.05). Admission head computed tomography imaging abnormalities (subarachnoid hemorrhage, intraventricular hemorrhage, and diffuse axonal injury), placement of an intracranial pressure (ICP) monitor, and administration of ICP-lowering therapies (hypertonic saline, mannitol, and thiopental) were associated with infections (p<0.05). Those with infections had fewer ventilator-free days, greater hospital lengths of stays, and were less likely to be discharged home. Logistic regression demonstrated that infections were independently associated with use of hypertonic saline (odds ratio [OR], 4.46; p=0.001) and higher ISS (OR, 1.05; p=0.028). In summary, infections were prevalent in sTBI patients and were associated with greater head-imaging abnormalities and use of ICP-lowering therapies. Hypertonic saline administration was strongly associated with infection, but further analyses are required to determine the nature of this relationship. Fever was a poor indicator of infection after sTBI.

Entities:  

Mesh:

Year:  2013        PMID: 24093309     DOI: 10.1089/neu.2013.2904

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  14 in total

Review 1.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Chronic Alterations in Systemic Immune Function after Traumatic Brain Injury.

Authors:  Rodney M Ritzel; Sarah J Doran; James P Barrett; Rebecca J Henry; Elise L Ma; Alan I Faden; David J Loane
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

3.  Subarachnoid hemorrhage prevalence and its association with short-term outcome in pediatric severe traumatic brain injury.

Authors:  Elana Hochstadter; Tanya Charyk Stewart; Ibrahim M Alharfi; Adrianna Ranger; Douglas D Fraser
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

4.  Extubation Failure and Tracheostomy Placement in Children with Acute Neurocritical Illness.

Authors:  Ellen C Cohn; Tammy S Robertson; Stacey A Scott; Andre M Finley; Rong Huang; Darryl K Miles
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

5.  Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury.

Authors:  Mitchell Hamele; Chris Stockmann; Meghan Cirulis; Jay Riva-Cambrin; Ryan Metzger; Tellen D Bennett; Susan L Bratton
Journal:  J Neurotrauma       Date:  2015-10-02       Impact factor: 5.269

6.  STAT1 contributes to microglial/macrophage inflammation and neurological dysfunction in a mouse model of traumatic brain injury.

Authors:  Yongfang Zhao; Cheng Ma; Caixia Chen; Sicheng Li; Yangfan Wang; Tuo Yang; R Anne Stetler; Michael V L Bennett; C Edward Dixon; Jun Chen; Yejie Shi
Journal:  J Neurosci       Date:  2022-08-18       Impact factor: 6.709

7.  Prevalence of respiratory colonisations and related antibiotic resistances among paediatric tracheostomised patients of a long-term rehabilitation centre in Italy.

Authors:  M Pozzi; P Pellegrino; S Galbiati; M Granziera; F Locatelli; C Carnovale; V Perrone; S Antoniazzi; C Perrotta; S Strazzer; E Clementi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-09       Impact factor: 3.267

8.  Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients.

Authors:  Meghan M Cirulis; Mitchell T Hamele; Chris R Stockmann; Tellen D Bennett; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2016-02       Impact factor: 3.624

Review 9.  Central nervous system injury-induced immune suppression.

Authors:  Eric A Sribnick; Phillip G Popovich; Mark W Hall
Journal:  Neurosurg Focus       Date:  2022-02       Impact factor: 4.047

10.  Development of a Mortality Prediction Tool in Pediatric Severe Traumatic Brain Injury.

Authors:  Kawmadi Abeytunge; Michael R Miller; Saoirse Cameron; Tanya Charyk Stewart; Ibrahim Alharfi; Douglas D Fraser; Janice A Tijssen
Journal:  Neurotrauma Rep       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.